CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Neurovive Pharmaceutical AB Company Snapshot
Neurovive Pharmaceutical AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neurovive Pharmaceutical AB with three other companies in this sector in Sweden: Eurocine Vaccines AB (2015 sales of 550,000.00 Swedish Kronor [US$61,765.00 ] ), Xintela AB (757,000.00 Swedish Kronor [US$85,011.10 ] ), and European Institute of Science AB (1.23 million Swedish Kronor [US$138,131.70 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Neurovive Pharmaceutical AB
  Stock Performance Chart for Neurovive Pharmaceutical AB
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 3.56
(Figures in Swedish Kronor)
1 Week 2.6%   13 Weeks 2.0%  
4 Weeks 12.3%   52 Weeks -60.1%  
 
Neurovive Pharmaceutical AB Key Data:
  Ticker: NVP Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 2,502,000
(Year Ending Jan 2016).
Employees: 18
  Currency: Swedish Kronor Market Cap: 176,072,776
  Fiscal Yr Ends: December Shares Outstanding: 49,458,645
  Share Type: Aktie Closely Held Shares: 17,629,369
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.